Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$0.28 - $0.48 $2,966 - $5,084
10,593 Added 103.98%
20,781 $7,000
Q1 2024

May 13, 2024

SELL
$0.21 - $0.69 $912 - $2,996
-4,343 Reduced 29.89%
10,188 $4,000
Q4 2023

Feb 13, 2024

BUY
$0.26 - $0.61 $3,778 - $8,863
14,531 New
14,531 $4,000

Others Institutions Holding PHGE

About BiomX Inc.


  • Ticker PHGE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,982,300
  • Market Cap $19.2M
  • Description
  • BiomX Inc., a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibr...
More about PHGE
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.